MedPath

Influence of Participation in Randomized Controlled Trials on adheRence to Medicines' Intake and regUlar viSits to the docTor

Completed
Conditions
Adherence, Patient
Interventions
Other: Not Provided
Registration Number
NCT03883282
Lead Sponsor
National Research Center for Preventive Medicine
Brief Summary

A prospective non-interventional single-center study aimed to evaluate the influence of participation in international randomized controlled trials (RCT) of cardiovascular patients on their compliance and adherence to medicines' intake and regular visits to the doctor in comparison with those patients, who had never participated in RCT within the outpatient registry PROFILE (prospective, observational study).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
control groupNot Provided- Patients who have never participated in RCT
study groupNot ProvidedPatients who have been participated in RCT in the period from 2011 to 2018 (study group)
Primary Outcome Measures
NameTimeMethod
Assessment of motives of enrollment in a trial and patient's attitude to RCT based on elaborated questionnaires for both groupson enrollment

The specially designed questionnaire for the study group includes 9 questions. Based on the data obtained, we will be able to draw conclusions about the motives for participating in RCTs, the level of trust towards a doctor, and adherence to treatment after the end of the RCT.

The questionnaire for the control group includes 8 questions with 3 possible answers as well. Based on the data obtained, we will determine the level of patient awareness of RCTs and the willingness to participate in the trial in the future. This questionnaire is exploratory, each question is considered individually, which allows us to make a more detailed analysis of various aspects of our study.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

National Research Center for Preventive Medicine

🇷🇺

Moscow, Russian Federation

© Copyright 2025. All Rights Reserved by MedPath